These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 7882032)

  • 1. MK-801 does not prevent acute stimulatory effects of amphetamine or cocaine on locomotor activity or extracellular dopamine levels in rat nucleus accumbens.
    Wolf ME; Xue CJ; White FJ; Dahlin SL
    Brain Res; 1994 Dec; 666(2):223-31. PubMed ID: 7882032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine.
    Wolf ME; White FJ; Hu XT
    J Neurosci; 1994 Mar; 14(3 Pt 2):1735-45. PubMed ID: 8126567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization.
    Wolf ME; Jeziorski M
    Brain Res; 1993 Jun; 613(2):291-4. PubMed ID: 8186979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dizocilpine [(+)-MK-801] on the expression of associative and non-associative sensitization to D-amphetamine.
    Grönig M; Atalla A; Kuschinsky K
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Feb; 369(2):228-31. PubMed ID: 14673514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine.
    Kalivas PW; Alesdatter JE
    J Pharmacol Exp Ther; 1993 Oct; 267(1):486-95. PubMed ID: 8229779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphine and amphetamine sensitization in rats demonstrated under moderate- and high-dose NMDA receptor blockade with MK-801 (dizocilpine).
    Ranaldi R; Munn E; Neklesa T; Wise RA
    Psychopharmacology (Berl); 2000 Aug; 151(2-3):192-201. PubMed ID: 10972465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproate blocks high-dose methamphetamine-induced behavioral cross-sensitization to locomotion-inducing effect of dizocilpine (MK-801), but not methamphetamine.
    Ito K; Abekawa T; Koyama T
    Psychopharmacology (Berl); 2006 Jul; 186(4):525-33. PubMed ID: 16758239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens.
    Pontieri FE; Tanda G; Di Chiara G
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12304-8. PubMed ID: 8618890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single exposure to restraint stress induces behavioral and neurochemical sensitization to stimulating effects of amphetamine: involvement of NMDA receptors.
    Pacchioni AM; Gioino G; Assis A; Cancela LM
    Ann N Y Acad Sci; 2002 Jun; 965():233-46. PubMed ID: 12105099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different neural mechanisms underlie dizocilpine maleate- and dopamine agonist-induced locomotor activity.
    Mele A; Thomas DN; Pert A
    Neuroscience; 1998 Jan; 82(1):43-58. PubMed ID: 9483502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between development of cross-sensitization to MK-801 and delayed increases in glutamate levels in the nucleus accumbens induced by a high dose of methamphetamine.
    Ito K; Abekawa T; Koyama T
    Psychopharmacology (Berl); 2006 Aug; 187(3):293-302. PubMed ID: 16850286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine.
    Pierce RC; Kalivas PW
    J Pharmacol Exp Ther; 1995 Nov; 275(2):1019-29. PubMed ID: 7473128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A glutamate-dopamine interaction in the persistent enhanced response to amphetamine in nucleus accumbens core but not shell following a single restraint stress.
    Pacchioni AM; Cador M; Bregonzio C; Cancela LM
    Neuropsychopharmacology; 2007 Mar; 32(3):682-92. PubMed ID: 16641941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in dopamine responsiveness to drugs of abuse in the nucleus accumbens shell and core of Lewis and Fischer 344 rats.
    Cadoni C; Di Chiara G
    J Neurochem; 2007 Oct; 103(2):487-99. PubMed ID: 17666048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychostimulant sensitization: differential changes in accumbal shell and core dopamine.
    Cadoni C; Solinas M; Di Chiara G
    Eur J Pharmacol; 2000 Jan; 388(1):69-76. PubMed ID: 10657548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphetamine, cocaine, and fencamfamine: relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics.
    Kuczenski R; Segal DS; Aizenstein ML
    J Neurosci; 1991 Sep; 11(9):2703-12. PubMed ID: 1715389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychostimulant-induced behavioral sensitization depends on nicotinic receptor activation.
    Schoffelmeer AN; De Vries TJ; Wardeh G; van de Ven HW; Vanderschuren LJ
    J Neurosci; 2002 Apr; 22(8):3269-76. PubMed ID: 11943828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitrous oxide and xenon prevent amphetamine-induced carrier-mediated dopamine release in a memantine-like fashion and protect against behavioral sensitization.
    David HN; Ansseau M; Lemaire M; Abraini JH
    Biol Psychiatry; 2006 Jul; 60(1):49-57. PubMed ID: 16427030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral sensitization to MK-801 (dizocilpine): neurochemical and electrophysiological correlates in the mesoaccumbens dopamine system.
    Wolf ME; White FJ; Hu XT
    Behav Pharmacol; 1993; 4(4):429-442. PubMed ID: 11224212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-HT(6) receptor antagonism potentiates the behavioral and neurochemical effects of amphetamine but not cocaine.
    Frantz KJ; Hansson KJ; Stouffer DG; Parsons LH
    Neuropharmacology; 2002 Feb; 42(2):170-80. PubMed ID: 11804613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.